Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
Get the latest updates from New medicines: human directly as they happen.
Follow now 400 followers
Last updated 8 days ago
8 days ago
Human medicines European public assessment report (EPAR): Obodence, denosumab, Status: Opinion
8 days ago
Human medicines European public assessment report (EPAR): Xbryk, denosumab, Status: Opinion
8 days ago
Human medicines European public assessment report (EPAR): Lazcluze, lazertinib, Status: Opinion
8 days ago
Human medicines European public assessment report (EPAR): Gohibic, vilobelimab, Status: Opinion
8 days ago
Human medicines European public assessment report (EPAR): Augtyro, repotrectinib, Status: Opinion
8 days ago
Human medicines European public assessment report (EPAR): Ahzantive, aflibercept, Status: Opinion
8 days ago
Human medicines European public assessment report (EPAR): Kizfizo, temozolomide, Status: Opinion
11 days ago
Human medicines European public assessment report (EPAR): Cinainu, dry aqueous extract of...
12 days ago
Human medicines European public assessment report (EPAR): Baiama, aflibercept, Status: Opinion
about 1 month ago
Human medicines European public assessment report (EPAR): Fluad, influenza vaccine (surface antigen...
about 1 month ago
Human medicines European public assessment report (EPAR): Buprenorphine Neuraxpharm, buprenorphine, Status: Opinion
about 1 month ago
Human medicines European public assessment report (EPAR): Absimky, ustekinumab, Status: Opinion